FNY Managed Accounts’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
CS
FNY Managed Accounts's XBI Position: Q2 2016 in Review
FNY Managed Accounts sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2016, closing a stake of 10,000 shares — an estimated $517K sold.
FNY Managed Accounts first reported a position in XBI in Q3 2015 and held it in 2 quarters. The position peaked at $517K in Q1 2016. 201 funds tracked by Wall St. Rank hold XBI as of Q2 2016.
- FNY Managed Accounts reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2016 after selling out during the quarter.
- FNY Managed Accounts sold 10,000 State Street SPDR S&P Biotech ETF shares in Q2 2016, an estimated $517K.
- FNY Managed Accounts first reported a position in State Street SPDR S&P Biotech ETF in Q3 2015 and held it in 2 quarters.
- FNY Managed Accounts's State Street SPDR S&P Biotech ETF position peaked at $517K in Q1 2016.
- 201 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2016.
Based on FNY Managed Accounts's 13F filing for Q2 2016, filed 27 Jul 2016.